fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

FDA approval for the Agent drug-coated balloon to treat coronary in-stent restenosis in patients with coronary artery disease – Boston Scientific

Written by | 8 Mar 2024

Boston Scientific Corporation announced it has received FDA approval for the Agent Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary… read more.

The FDA has approved an expanded indication of the WaveWriter SCS systems for the treatment of chronic low back and leg pain – Boston Scientific

Written by | 15 Feb 2024

Boston Scientific Corporation announced that the FDA has approved an expanded indication of the WaveWriter SCS Systems for the treatment of chronic low back and leg pain in… read more.

FDA approval for Farapulse pulsed field ablation system – Boston Scientific

Written by | 3 Feb 2024

Boston Scientific Corporation announced it has received FDA approval for the Farapulse Pulsed Field Ablation (PFA) System. The Farapulse PFA System is indicated for the isolation of pulmonary… read more.

Boston Scientific closes acquisition of Relievant Medsystems, Inc. and with it Intracept Intraosseous Nerve Ablation System

Written by | 22 Nov 2023

Boston Scientific Corporation announced the close of its acquisition of Relievant Medsystems Inc., a company that offers the only FDA -cleared Intracept Intraosseous Nerve Ablation System, a therapy… read more.

Boston Scientific Corporation announced it has received FDA approval for the latest-generation Watchman FLX Pro Left Atrial Appendage Closure device

Written by | 13 Sep 2023

Boston Scientific Corporation announced it has received approval for the latest-generation Watchman FLX Pro Left Atrial Appendage Closure (LAAC) Device. Designed to further advance the procedural performance and… read more.

FDA approval for the POLARx cryoablation system for the treatment of patients with paroxysmal atrial fibrillation – Boston Scientific

Written by | 18 Aug 2023

Boston Scientific Corporation announced it has received FDA approval for the POLARx Cryoablation System.The new system, which is indicated for the treatment of patients with paroxysmal atrial fibrillation… read more.

Primary results of the FROZEN-AF IDE trial with the POLARx cryoablation system – Boston Scientific

Written by | 4 Jun 2023

– Primary results of the FROZEN-AF IDE trial with the POLARx Cryoablation System : Results from the global, prospective, non-randomized, single-arm FROZEN-AF IDE study of the POLARx Cryoablation… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.